Given that virtually all constitutive vascular cells express ACE2, COVID-19 may potentiate AAA pathogenesis by enhancing aortic leukocyte recruitment and/or augmenting aortic wall inflammation [32]. Here, ACE2 is linked to triple-A syndrome.